CovidChloroV1, Main, Exploration, bibRecord, 000D50

Regulators split on antimalarials for COVID-19.

Identifieur interne : 000D50 ( Main/Exploration ); précédent : 000D49; suivant : 000D51

Regulators split on antimalarials for COVID-19.

Auteurs : Susan Jaffe

Source :

Lancet (London, England) [ 1474-547X ] ; 2020.

RBID : pubmed:32278373

Descripteurs français

KwdFr :
- Agrément de médicaments (législation et jurisprudence), Agrément de médicaments (organisation et administration), Antipaludiques (effets indésirables), Antipaludiques (ressources et distribution), Antipaludiques (usage thérapeutique), Betacoronavirus (MeSH), Chloroquine (effets indésirables), Chloroquine (ressources et distribution), Chloroquine (usage thérapeutique), Humains (MeSH), Hydroxychloroquine (effets indésirables), Hydroxychloroquine (ressources et distribution), Hydroxychloroquine (usage thérapeutique), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Pandémies (législation et jurisprudence), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (épidémiologie), Union européenne (MeSH), États-Unis (épidémiologie).
MESH :
- effets indésirables : Antipaludiques, Chloroquine, Hydroxychloroquine.
- législation et jurisprudence : Agrément de médicaments, Pandémies.
- organisation et administration : Agrément de médicaments.
- ressources et distribution : Antipaludiques, Chloroquine, Hydroxychloroquine.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Antipaludiques, Chloroquine, Hydroxychloroquine.
- épidémiologie : Infections à coronavirus, Pneumopathie virale, États-Unis.
- Betacoronavirus, Humains, Union européenne.
Wicri :
- geographic : États-Unis.

English descriptors

KwdEn :
- Antimalarials (adverse effects), Antimalarials (supply & distribution), Antimalarials (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Chloroquine (adverse effects), Chloroquine (supply & distribution), Chloroquine (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Drug Approval (legislation & jurisprudence), Drug Approval (organization & administration), European Union (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Hydroxychloroquine (supply & distribution), Hydroxychloroquine (therapeutic use), Pandemics (legislation & jurisprudence), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), SARS-CoV-2 (MeSH), United States (epidemiology).
MESH :
- chemical , adverse effects : Antimalarials, Chloroquine, Hydroxychloroquine.
- chemical , supply & distribution : Antimalarials, Chloroquine, Hydroxychloroquine.
- chemical , therapeutic use : Antimalarials, Chloroquine, Hydroxychloroquine.
- geographic , epidemiology : United States.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- legislation & jurisprudence : Drug Approval, Pandemics.
- organization & administration : Drug Approval.
- Betacoronavirus, COVID-19, European Union, Humans, SARS-CoV-2.

DOI: 10.1016/S0140-6736(20)30817-5
PubMed: 32278373
PubMed Central: PMC7146712

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001A02
to stream Main, to step Curation: 001A02

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Regulators split on antimalarials for COVID-19.</title>
<author><name sortKey="Jaffe, Susan" sort="Jaffe, Susan" uniqKey="Jaffe S" first="Susan" last="Jaffe">Susan Jaffe</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32278373</idno>
<idno type="pmid">32278373</idno>
<idno type="doi">10.1016/S0140-6736(20)30817-5</idno>
<idno type="pmc">PMC7146712</idno>
<idno type="wicri:Area/Main/Corpus">001A02</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A02</idno>
<idno type="wicri:Area/Main/Curation">001A02</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001A02</idno>
<idno type="wicri:Area/Main/Exploration">001A02</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Regulators split on antimalarials for COVID-19.</title>
<author><name sortKey="Jaffe, Susan" sort="Jaffe, Susan" uniqKey="Jaffe S" first="Susan" last="Jaffe">Susan Jaffe</name>
</author>
</analytic>
<series><title level="j">Lancet (London, England)</title>
<idno type="eISSN">1474-547X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (adverse effects)</term>
<term>Antimalarials (supply & distribution)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Chloroquine (adverse effects)</term>
<term>Chloroquine (supply & distribution)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Drug Approval (legislation & jurisprudence)</term>
<term>Drug Approval (organization & administration)</term>
<term>European Union (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Hydroxychloroquine (supply & distribution)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Pandemics (legislation & jurisprudence)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agrément de médicaments (législation et jurisprudence)</term>
<term>Agrément de médicaments (organisation et administration)</term>
<term>Antipaludiques (effets indésirables)</term>
<term>Antipaludiques (ressources et distribution)</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Chloroquine (effets indésirables)</term>
<term>Chloroquine (ressources et distribution)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (effets indésirables)</term>
<term>Hydroxychloroquine (ressources et distribution)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Pandémies (législation et jurisprudence)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Union européenne (MeSH)</term>
<term>États-Unis (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antimalarials</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Antimalarials</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antipaludiques</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Drug Approval</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Agrément de médicaments</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Agrément de médicaments</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Drug Approval</term>
</keywords>
<keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Antipaludiques</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antipaludiques</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>European Union</term>
<term>Humans</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term>
<term>Humains</term>
<term>Union européenne</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32278373</PMID>
<DateCompleted><Year>2020</Year>
<Month>04</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>395</Volume>
<Issue>10231</Issue>
<PubDate><Year>2020</Year>
<Month>04</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>Lancet (London, England)</Title>
<ISOAbbreviation>Lancet</ISOAbbreviation>
</Journal>
<ArticleTitle>Regulators split on antimalarials for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>1179</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0140-6736(20)30817-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(20)30817-5</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jaffe</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Lancet</MedlineTA>
<NlmUniqueID>2985213R</NlmUniqueID>
<ISSNLinking>0140-6736</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017277" MajorTopicYN="N">Drug Approval</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="Y">legislation & jurisprudence</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005062" MajorTopicYN="N">European Union</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32278373</ArticleId>
<ArticleId IdType="pii">S0140-6736(20)30817-5</ArticleId>
<ArticleId IdType="doi">10.1016/S0140-6736(20)30817-5</ArticleId>
<ArticleId IdType="pmc">PMC7146712</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Jaffe, Susan" sort="Jaffe, Susan" uniqKey="Jaffe S" first="Susan" last="Jaffe">Susan Jaffe</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D50 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32278373
   |texte=   Regulators split on antimalarials for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32278373" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Regulators split on antimalarials for COVID-19.

Regulators split on antimalarials for COVID-19.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki